Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1

NCT01226771 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
105
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Göteborg University

Collaborators